Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Leukemias

Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

Leukemia volume 21, pages 2145–2152 (2007)Cite this article

Abstract

Natural killer (NK) cells are the first lymphocytes to recover after allogeneic stem cell transplantation (SCT) and can exert powerful graft-versus-leukemia (GVL) effects determining transplant outcome. Conditions governing NK cell alloreactivity and the role of NK recovery in sibling SCT are not well defined. NK cells on day 30 post-transplant (NK30) were measured in 54 SCT recipients with leukemia and donor and recipient killer immunoglobulin-like receptor (KIR) genotype determined. In univariate analysis, donor KIR genes 2DL5A, 2DS1, 3DS1 (positive in 46%) and higher numbers of inhibitory donor KIR correlated with higher NK30 counts and were associated with improved transplant outcome. NK30 counts also correlated directly with the transplant CD34 cell dose and inversely with the CD3+ cell dose. In multivariate analysis, the NK30 emerged as the single independent determinant of transplant outcome. Patients with NK30 >150/μl had less relapse (HR 18.3, P=0.039), acute graft-versus-host disease (HR 3.2, P=0.03), non-relapse mortality (HR 10.7, P=0.028) and improved survival (HR 11.4, P=0.03). Results suggest that T cell-depleted SCT might be improved and the GVL effect enhanced by selecting donors with favorable KIR genotype, and by optimizing CD34 and CD3 doses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333–339.

    CAS  Google Scholar 

  2. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2100.

    Article  CAS  Google Scholar 

  3. Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2006; 107: 1688–1695.

    Article  CAS  Google Scholar 

  4. Zeis M, Uharek L, Glass B, Gaska T, Steinmann J, Gassmann W et al. Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation 1995; 59: 1734–1736.

    Article  CAS  Google Scholar 

  5. Hauch M, Gazzola MV, Small T, Bordignon C, Barnett L, Cunningham I et al. Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 1990; 75: 2250–2262.

    CAS  Google Scholar 

  6. Murphy WJ, Reynolds CW, Tiberghien P, Longo DL . Natural killer cells and bone marrow transplantation. J Natl Cancer Inst 1993; 85: 1475–1482.

    Article  CAS  Google Scholar 

  7. Brooks AG, Boyington JC, Sun PD . Natural killer cell recognition of HLA class I molecules. Rev Immunogenet 2000; 2: 433–448.

    CAS  Google Scholar 

  8. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD . Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000; 405: 537–543.

    Article  CAS  Google Scholar 

  9. Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A . Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. Cytotherapy 2006; 8: 554–558.

    Article  CAS  Google Scholar 

  10. Jiang YZ, Barrett AJ, Goldman JM, Mavroudis DA . Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 1997; 74: 1–6.

    Article  CAS  Google Scholar 

  11. Mackinnon S, Bungey J, Chase A, Paulsen W, Hows JM, Goldman JM . Origin and function of adherent lymphokine activated killer cells in patients with chronic myeloid leukaemia who relapse following bone marrow transplantation. Br J Haematol 1991; 77: 60–65.

    Article  CAS  Google Scholar 

  12. Sconocchia G, Lau M, Provenzano M, Rezvani K, Wongsena W, Fujiwara H et al. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions. Blood 2005; 106: 3666–3672.

    Article  CAS  Google Scholar 

  13. Sconocchia G, del PD, Barrett AJ . Non-classical antileukemia activity of early recovering NK cells after induction chemotherapy and HLA-identical stem cell transplantation in myeloid leukemias. Leukemia 2006; 20: 1632–1633.

    Article  CAS  Google Scholar 

  14. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521–1526.

    Article  CAS  Google Scholar 

  15. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105: 4878–4884.

    Article  CAS  Google Scholar 

  16. De SD, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 2005; 65: 519–528.

    Article  Google Scholar 

  17. Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540–6545.

    Article  CAS  Google Scholar 

  18. Bishara A, De SD, Witt CC, Brautbar C, Christiansen FT, Or R et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 2004; 63: 204–211.

    Article  CAS  Google Scholar 

  19. Chen C, Busson M, Rocha V, Appert ML, Lepage V, Dulphy N et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 2006; 38: 437–444.

    Article  CAS  Google Scholar 

  20. Verheyden S, Schots R, Duquet W, Demanet C . A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 2005; 19: 1446–1451.

    Article  CAS  Google Scholar 

  21. Montero A, Savani BN, Shenoy A, Read EJ, Carter CS, Leitman SF et al. T cell depleted peripheral blood stem cell allotransplantation with T cell add back for patients with hematological malignancies: effect of chronic GVHD on outcome. Biol Blood Marrow Transplant 2006; 12: 1318–1325.

    Article  Google Scholar 

  22. Dupont B, Hsu KC . Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Curr Opin Immunol 2004; 16: 634–643.

    Article  CAS  Google Scholar 

  23. Gagne K, Brizard G, Gueglio B, Milpied N, Herry P, Bonneville F et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63: 271–280.

    Article  CAS  Google Scholar 

  24. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT . Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999; 68: 1784–1789.

    Article  CAS  Google Scholar 

  25. Crum KA, Logue SE, Curran MD, Middleton D . Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000; 56: 313–326.

    Article  CAS  Google Scholar 

  26. Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005; 106: 4370–4376.

    Article  CAS  Google Scholar 

  27. Sun JY, Dagis A, Gaidulis L, Miller MM, Rodriguez R, Parker P et al. Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients. Biol Blood Marrow Transplant 2007; 13: 197–205.

    Article  Google Scholar 

  28. Singh AK, Savani BN, Albert PS, Barrett AJ . Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation. Biol Blood Marrow Transplant 2007; 13: 339–344.

    Article  Google Scholar 

  29. Ringden O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS et al. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol 2003; 121: 874–885.

    Article  Google Scholar 

  30. Warren HS . Using carboxyfluorescein diacetate succinimidyl ester to monitor human NK cell division: analysis of the effect of activating and inhibitory class I MHC receptors. Immunol Cell Biol 1999; 77: 544–551.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stem Cell Transplantation Section, Hematology Branch, National Institutes of Health, Bethesda, MD, USA

    B N Savani, S Mielke, K Rezvani, A S M Yong, J Zeilah, R Childs, N Hensel & A J Barrett

  2. Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA

    S Adams & M Uribe

  3. Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD, USA

    R Kurlander

  4. Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    R Srinivasan

Authors
  1. B N Savani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Mielke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Uribe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Rezvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A S M Yong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Zeilah
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R Kurlander
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R Srinivasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R Childs
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. N Hensel
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A J Barrett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A J Barrett.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savani, B., Mielke, S., Adams, S. et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 21, 2145–2152 (2007). https://doi.org/10.1038/sj.leu.2404892

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404892

Keywords

This article is cited by

Search

Advanced search

Quick links